Squarepoint’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Sell
55,355
-383,576
-87% -$10.2M ﹤0.01% 1310
2025
Q1
$10.6M Buy
438,931
+171,626
+64% +$4.14M 0.01% 529
2024
Q4
$10.8M Buy
267,305
+233,051
+680% +$9.38M 0.01% 520
2024
Q3
$2.17M Sell
34,254
-107,566
-76% -$6.81M ﹤0.01% 1099
2024
Q2
$7.52M Buy
+141,820
New +$7.52M 0.01% 550
2024
Q1
Sell
-50,603
Closed -$942K 2971
2023
Q4
$942K Buy
50,603
+23,673
+88% +$441K ﹤0.01% 1374
2023
Q3
$298K Buy
+26,930
New +$298K ﹤0.01% 1933
2023
Q2
Sell
-26,063
Closed -$434K 2868
2023
Q1
$434K Buy
+26,063
New +$434K ﹤0.01% 1533
2022
Q4
Sell
-14,382
Closed -$39K 2646
2022
Q3
$39K Sell
14,382
-381
-3% -$1.03K ﹤0.01% 1971
2022
Q2
$43K Sell
14,763
-3,077
-17% -$8.96K ﹤0.01% 1972
2022
Q1
$54K Sell
17,840
-50,279
-74% -$152K ﹤0.01% 2101
2021
Q4
$313K Buy
68,119
+37,704
+124% +$173K ﹤0.01% 1844
2021
Q3
$191K Sell
30,415
-68,751
-69% -$432K ﹤0.01% 1848
2021
Q2
$594K Sell
99,166
-7,089
-7% -$42.5K ﹤0.01% 1508
2021
Q1
$672K Buy
106,255
+61,907
+140% +$392K ﹤0.01% 1335
2020
Q4
$250K Sell
44,348
-55,336
-56% -$312K ﹤0.01% 1996
2020
Q3
$580K Buy
+99,684
New +$580K 0.01% 1241
2020
Q1
Sell
-110,347
Closed -$885K 2485
2019
Q4
$885K Buy
110,347
+29,868
+37% +$240K 0.01% 1388
2019
Q3
$554K Sell
80,479
-55,239
-41% -$380K ﹤0.01% 1513
2019
Q2
$1.13M Buy
135,718
+85,118
+168% +$706K 0.01% 1177
2019
Q1
$503K Sell
50,600
-25,343
-33% -$252K 0.01% 1460
2018
Q4
$581K Buy
+75,943
New +$581K 0.01% 1157